The HEMOCOVID-19 clinical trial, carried out in 10 hospitals from 5 countries, aims to non-invasively assess, through continuous-wave near-infrared spectroscopy (CW-NIRS), the microvascular and endothelial health in COVID-19 patients admitted to intensive care. We achieve this by performing a vascular occlusion test on the forearm muscle while continuously measuring local tissue oxygen saturation and hemoglobin concentration. We found significant alterations in systemic microcirculation of COVID-19 patients with respect to healthy subjects (i.e. slower deoxygenation during the ischemia and reoxygenation after releasing the cuff, and lower hyperemic response). In addition, we found that, within the group of COVID-19 patients, the systemic microcirculation alterations correlate with severity of pulmonary disease.
We present the HEMOCOVID-19 study spanning four countries and eight hospitals where near-infrared spectroscopy is utilized to evaluate microvascular and endothelial health of severe COVID-19 patients at the intensive care.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.